Minerals Technologies Inc.

DB:MNK Stock Report

Market Cap: €2.6b

Minerals Technologies Valuation

Is MNK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MNK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MNK (€76.5) is trading below our estimate of fair value (€143.89)

Significantly Below Fair Value: MNK is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MNK?

Key metric: As MNK is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MNK. This is calculated by dividing MNK's market cap by their current earnings.
What is MNK's PE Ratio?
PE Ratio17.4x
EarningsUS$152.80m
Market CapUS$2.66b

Price to Earnings Ratio vs Peers

How does MNK's PE Ratio compare to its peers?

The above table shows the PE ratio for MNK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average28.5x
WCH Wacker Chemie
28.3x37.0%€3.5b
EVK Evonik Industries
35.8x33.1%€8.2b
ACT AlzChem Group
12.1x12.6%€606.5m
SY1 Symrise
37.8x13.2%€14.8b
MNK Minerals Technologies
17.4x23.1%€2.7b

Price-To-Earnings vs Peers: MNK is good value based on its Price-To-Earnings Ratio (17.4x) compared to the peer average (28.5x).

Price to Earnings Ratio vs Industry

How does MNK's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
MNK 17.4xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: MNK is expensive based on its Price-To-Earnings Ratio (17.4x) compared to the European Chemicals industry average (16.9x).

Price to Earnings Ratio vs Fair Ratio

What is MNK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MNK PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.4x
Fair PE Ratio17.8x

Price-To-Earnings vs Fair Ratio: MNK is good value based on its Price-To-Earnings Ratio (17.4x) compared to the estimated Fair Price-To-Earnings Ratio (17.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MNK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€76.50
€91.53
+19.6%
3.6%€97.07€88.75n/a4
Nov ’25€69.00
€91.53
+32.6%
3.6%€97.07€88.75n/a4
Oct ’25€69.00
€90.48
+31.1%
3.2%€94.30€86.22n/a4
Sep ’25€67.50
€92.04
+36.4%
3.9%€97.13€86.95n/a4
Aug ’25€72.00
€92.04
+27.8%
3.9%€97.13€86.95n/a4
Jul ’25€77.00
€88.75
+15.3%
5.7%€91.97€80.01n/a4
Jun ’25€79.00
€88.75
+12.3%
5.7%€91.97€80.01n/a4
May ’25€70.00
€87.44
+24.9%
6.7%€93.27€81.14n/a4
Apr ’25€70.50
€81.20
+15.2%
7.0%€87.91€72.18n/a4
Mar ’25€66.50
€80.76
+21.4%
7.4%€88.44€72.61n/a4
Feb ’25€60.50
€72.86
+20.4%
8.1%€77.47€64.56n/a3
Jan ’25€65.00
€71.56
+10.1%
8.1%€76.09€63.41n/a3
Dec ’24€57.00
€68.66
+20.5%
10.4%€78.43€61.42n/a3
Nov ’24€51.00
€68.66
+34.6%
10.4%€78.43€61.42€69.003
Oct ’24€52.00
€69.11
+32.9%
11.4%€80.03€61.84€69.003
Sep ’24€56.00
€69.11
+23.4%
11.4%€80.03€61.84€67.503
Aug ’24€55.50
€69.11
+24.5%
11.4%€80.03€61.84€72.003
Jul ’24€51.50
€73.64
+43.0%
11.4%€82.02€65.25€77.002
Jun ’24€52.00
€73.64
+41.6%
11.4%€82.02€65.25€79.002
May ’24€50.50
€72.01
+42.6%
11.4%€80.21€63.81€70.002
Apr ’24€54.00
€72.24
+33.8%
9.7%€79.23€65.25€70.502
Mar ’24€57.00
€72.24
+26.7%
9.7%€79.23€65.25€66.502
Feb ’24€65.00
€78.12
+20.2%
5.9%€82.71€73.52€60.502
Jan ’24€57.00
€86.04
+50.9%
5.9%€91.10€80.98€65.002
Dec ’23€57.50
€86.04
+49.6%
5.9%€91.10€80.98€57.002
Nov ’23€55.50
€86.04
+55.0%
5.9%€91.10€80.98€51.002

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Compañía de Minas BuenaventuraA

US$3.1b

Engages in the exploration, development, construction, and operation of mineral processing business.

MBU

US$11.70

7D

0%

1Y

41.0%

Stanmore Resources

AU$2.8b

Engages in the exploration, development, production, and sale of metallurgical coal in Australia.

S0D

AU$1.91

7D

4.9%

1Y

-15.5%

Arkema

€5.7b

Manufactures and sells specialty chemicals and advanced materials worldwide.

V1S

€74.55

7D

-4.4%

1Y

-19.9%